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Abstract: Carbon nanostructures (CNs) are amongst the most promising biorecognition 
nanomaterials due to their unprecedented optical, electrical and structural properties.  
As such, CNs may be harnessed to tackle the detrimental public health and socio-economic 
adversities associated with neurodegenerative diseases (NDs). In particular, CNs may be 
tailored for a specific determination of biomarkers indicative of NDs. However, the realization 
of such a biosensor represents a significant technological challenge in the uniform fabrication 
of CNs with outstanding qualities in order to facilitate a highly-sensitive detection of 
biomarkers suspended in complex biological environments. Notably, the versatility of 
plasma-based techniques for the synthesis and surface modification of CNs may be 
embraced to optimize the biorecognition performance and capabilities. This review surveys 
the recent advances in CN-based biosensors, and highlights the benefits of plasma-processing 
techniques to enable, enhance, and tailor the performance and optimize the fabrication  
of CNs, towards the construction of biosensors with unparalleled performance for the  
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1. Introduction 
Neurodegenerative diseases (NDs) such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) 
are becoming more prevalent with the ageing population. At present, over 40 million individuals 
worldwide are affected by AD or PD [1,2]. More critically, this amassing population of sufferers may 
see a three-fold increase by 2050 [3,4]. In addition to human suffering, this represents not only a 
significant loss in productivity, but also a huge burden on the heath care system and the economy [5]. 
Whilst a cure is not yet available, the symptoms associated with ND may be more effectively managed 
with early intervention therapies and lifestyle adjustments if they are diagnosed as early as possible. 
Unfortunately, NDs are usually first diagnosed symptomatically, once the disease has progressed  
to the point where it is noticeable. The identification of clinical markers (i.e., Lewy bodies in the PD  
case [6] and Lewy-body dementia or plaques in the AD case [7,8]) is typically only possible post-mortem. 
Biomarkers, on the other hand, are good candidates for the early detection of ND. Early detection will 
enable medical practitioners to implement treatment strategies such as brain exercises and physical 
fitness regimes, and identify sufferers who may respond to drugs (e.g., for AD [9–11], and PD [12–14]) 
designed to slow the progression of the disease. This points to the critical importance of developing 
practical advanced sensors capable of detecting low concentrations of ND-related biomarkers 
(including, but not limited to, beta-Amyloid (Aβ) [15,16], alpha-Synuclein [17,18], mtDNA [19], and 
phospholipids [20]), and distinguish between their various mutated and misfolded forms (e.g., monomers, 
protofibrils, oligomers, and fibrils) in complex mixtures such as blood and cerebrospinal fluid (CSF), 
for a presymptomatic diagnosis and progressive monitoring of AD and PD. 
1.1. Biosensors 
Fundamentally, a biosensor is a device comprised of two elements—a biomolecular receptor capable 
of specific reaction with the target analyte, and a transducer which processes the biorecognition event 
into a measurable signal. Indeed, a diverse spectrum of electrochemical [21–26] and optoelectrical [27–29] 
biosensors has been recently developed for the detection of biomarkers indicative of AD or PD. 
However, these biosensors fall short in addressing one or more key criteria of device performance and 
fabrication. In particular, this includes a high sensitivity and specificity in physiochemical environments 
(i.e., blood or CSF), a rapid sensor response and regeneration, and an inexpensive device fabrication. 
Consequently, future innovations in the design of novel advanced materials towards the optimization 
of biosensors for ND biomarkers remain highly warranted. 
1.2. Advanced Materials: Carbon Nanostructures 
Notably, carbon nanostructures (CNs) (e.g., nanotubes, nanosheets, and nanowalls) inherit a 
multitude of characteristics that enable their versatility to simultaneously play the role of a specific 
receptor and a sensitive transducer. For instance, the mechanical robustness, high electrical conductivity, 
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superior optical properties, and ease of functionality of CNs, have been harnessed to realize a plethora 
of hierarchical biorecognition nanocomposites (see Sections 2.1, 2.2, 3.1, 3.2, and 4.1 below) which 
may be tailored for the determination of AD or PD biomarkers. Correspondingly, this highlights the 
necessity for a deterministic, resource-efficient, and practical synthesis for these hybrid nanostructures.  
1.3. From Fabrication to Performance: The Plasma Advantage 
Conventional approaches for the synthesis of carbon-based biorecognition structures have involved 
techniques such as lithography, wet chemical processing, and chemical vapor deposition (CVD). 
However, not only are these methods time consuming and energy-inefficient, but also the harsh 
environments involved have been responsible for inducing substrate damage, unwanted impurities, and 
non-uniformity in yield. Consequently, this leads to a poor reproducibility in device fabrication and  
a compromised biosensing performance. On the other hand, plasma-based techniques [30–33] for 
fabrication and surface treatment may be implemented to enable, enhance, and tailor the device 
performance and optimize the fabrication processes of CNs towards the construction of biosensors 
with superior properties, via a plethora of resource-efficient, eco-friendly, and inexpensive approaches 
(see Sections 2.3, 3.3, and 4.2 below). 
2. Graphene 
Graphene, a single-layer two-dimensional (2D) honeycomb lattice of sp
2
-hybridized carbon  
atoms [34–36], inherits an exceptional tensile strength [37], large specific surface area [38–40], ease  
of functionality [41,42], tunable band gap [43–45], low electrical noise [46,47], ballistic charge 
transport [48,49], and high charge carrier concentrations at room temperature [46,50]. Consequently,  
a wide variety of graphene-based electrical (Section 2.1) and optical (Section 2.2) biosensors have 
been realized through its unique physicochemical properties.  
2.1. Graphene-Based Electrical Biosensors 
Graphene-based field effect transistors (G-FETs) have been essential towards the developments for 
a label-free and real-time determination of biological complexes. In G-FETs, the surface of graphene 
serves as the interfacial element for biorecognition and transduction. Typically, target analytes are 
selectively detected by a specific binding with complementary biomolecules functionalized on the 
surface of graphene. In particular, a charged molecule (e.g., protein, DNA) adsorbed on the surface of 
graphene induces a perturbation in the local charge density, leading to a change in the channel conductance.  
In G-FET DNA biosensors, selectivity is enabled through the hybridization between complementary 
DNAs. For instance, single-stranded (ss) DNAs have been tethered on the surface of chemically modified 
graphene through linker molecules for a specific detection of the complementary DNA [51–54]. 
Notably, the first G-FET DNA biosensor was established by Mohanty et al. [51], where graphene 
oxide (GO) sheets were prepared by a modified Hummers method [55–57] and backgated with  
silica. The functional groups on GO were utilized to immobilize single-stranded fluorescent  
DNA probes for a selective detection of complementary target DNAs through successive base-pairing 
hybridization/dehybridization interactions and restorations in GO conductivity. Subsequently, innovations 
Materials 2014, 7 4899 
 
 
in DNA G-FETs including electrolyte-gated setups [58,59], CVD-prepared graphene for low-noise 
performance [60], and an increased loading of probe DNAs through nanoparticle (NP) functionalized 
graphene-based substrates [58,59], have driven improvements in the detection limit of DNAs to the 
nM and pM concentrations. Most recently, Cai et al. [61] have designed a reduced graphene oxide 
(RGO)-FET DNA biosensor capable of selectively identifying single-based mismatched DNAs and 
noncomplementary DNAs, with a resolution of 100 fM, which is one order of magnitude lower than 
previously reported G-FET DNA biosensors. In this biosensor, peptide nucleic acid (PNA) (instead of 
ssDNA) was employed as the capture probe, and DNA recognition was achieved through PNA-DNA 
hybridization on the RGO surface. Above all, these G-FETs with the capability of sequence-specific 
DNA recognition may be tailored for a label-free and real-time determination of DNA mutations 
indicative of AD or PD.  
A similar biorecognition protocol has been developed for proteins (i.e., immunoglobulins), where 
selectivity was enabled through antibody-antigen [62–65] or protein-aptamer [66–69] binding at the 
graphene interface. Moreover, the probe biomolecules (e.g., antibodies, aptamers, ssDNAs) may be 
labeled on the surface of chemically modified graphene via (i) chemical linkers [65,67,70]; or  
(ii) conjugation with NPs adsorbed on its surface [63,64,70]. The chemical-linker-based approach has 
been adopted by Kurkina et al. [65] to realize a RGO-FET immunosensor for Aβ peptides. The surface 
of RGO was initially functionalized with Staphylococcus aureus protein A (SpA) through 
carbodiimide coupling [71], and subsequently, anti-Aβ-antibodies were immobilized on SpA-RGO 
through the specificity of SpA with the Fc antibody fragments [72]. This immunosensor reported  
a detection limit of 1 fM Aβ—an order of magnitude improvement compared to commercial ELISA 
assays for Aβ quantification in biological fluids [73]. In the second approach based on conjugated NPs, 
not only do NPs increase the load of probe biomolecules, it also enables an outward orientation of 
binding sites (i.e., antibody Fab region), and hence optimizes the device sensitivity by maximizing  
the number of available capture sites for the target proteins. For instance, Mao et al. [63,64] and 
Myung et al. [70] have established a highly-sensitive and selective G-FET protein biosensor, based on 
RGO decorated with AuNP-antibody conjugates for the determination of complementary antigens. The 
biorecognition substrate was also prepared by thermal reduction from GO [63], whereby a detection 
limit in the order of ng/mL was deduced, and the specificity in antibody-antigen binding mechanism 
was demonstrated for the immobilization of non-complementary antigens including immunoglobulin-G 
(Ig-G), immunoglobulin-M (Ig-M) and horseradish peroxide (HRP). In Figure 1a the fabrication of a 
similar NP composite-based G-FET immunosensor [70] is illustrated, where reduced graphene oxide 
(RGO)-encapsulated nanoparticle (NP) arrays were implemented for a highly sensitive, selective and 
label-free detection of breast cancer biomarkers. Moreover, the limit of protein detection may be 
enhanced by reducing the effects of Debye screening on the immobilized target proteins. In particular, 
this has been demonstrated by Kim et al. [62,68], where aptamers (short oligonucleotides) were 
utilized as probe biomolecules to achieve detection limits in the femto- and atto-molar ranges.  
On the other hand, graphene-based electrochemical (GEC) biosensors rely on redox reactions 
between the probe and target biomolecules for transduction. In comparison with G-FETs, GEC 
biosensors are attractive as they present a simpler and hence less expensive electrode fabrication. 
Consequently, a diverse spectrum of highly-selective and sensitive GEC biosensors have been 
developed for the determination of disease-specific protein biomarkers [74–77], in conjunction with 
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nucleic acids (i.e., DNA bases) and DNA sequences [78–90], which may be tailored for the realization 
of single nucleotide polymorphism (SNP) assays for DNA mutations correlated with the development 
of AD or PD. 
Figure 1. Graphene-based field effect transistors (FET), electrochemical, fluorescent 
resonance energy transfer (FRET), and surface enhanced Raman scattering (SERS)-active 
biosensing platforms. (a) A reduced graphene oxide (RGO)-encapsulated nanoparticle 
(NP) array for a highly sensitive, selective and label-free detection of breast cancer 
biomarkers. Reproduced from [70]; (b) Graphene oxide nanoplatelets (GONPs) utilized as 
electroactive labels for the detection of thrombin (THR). Reproduced from [91];  
(c) Schematic for the preparation of DNA-CdTe quantum dots (QDs) for a FRET assay of 
DNAs. Reproduced from [92]; (d) Preparation of a multiplexed SERS-active substrate 
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Figure 1. Cont. 
 
The properties of graphene, namely, its diverse functionalities, two-dimensional structure, and  
high electrical conductivity, have been crucial towards the enhancement in selectivity and sensitivity 
of electrochemical biosensors. In particular, graphene is typically integrated as an electrode coating in 
GEC biosensors as its surface may be functionalized with chemical linkers [75–77,94] or nanocomposites 
(e.g., nanoparticles, nanorods) [87,89,95], to facilitate the adsorption or immobilization of probe 
biomolecules (e.g., antibodies, ssDNAs) for a highly-sensitive and specific assay of the target analytes. 
For instance, a label-free GEC immunosensor with a resolution of 0.012 U/mL for the cancer 
biomarker, carbohydrate antigen 15-3 (CA 15-3), was reported [75]. A glassy carbon electrode was 
coated with nitrogen-doped graphene sheets for the immobilization of CA 15-3 specific antibodies 
through its Fc site. The modified electrode was subsequently immersed in BSA to prevent non-specific 
binding, before the target antigens were introduced. While metal nanoparticles have been commonly 
employed as electroactive labels in electrochemical sandwich assays [96,97], a novel aptasensor which 
exploits the inherent electroactivity of graphene oxide nanoplatelets (GONPs) for labeling was recently 
developed (Figure 1b) [91]. In this assay, the basis of detection lies in the ability of GO to be 
electrochemically reduced to provide a well-defined reduction “wave”, in which a single GONP 
(dimension 50 × 50 nm) induces a reduction signal by accepting electrons from the modified electrode 
surface. By using GONPs as an inherently electroactive label, thrombin detection was demonstrated in 
the concentration range of 3 pM to 0.3 µM, with good selectivity of the aptamer towards interferences 
by bovine serum albumin (BSA), IgG and avidin. Most importantly, these GEC biorecognition 
platforms may be adapted to the determination of protein biomarkers and DNA mutations indicative of 
AD or PD. 
2.2. Graphene-Based Optical Biosensors 
Optical biosensors have predominantly capitalized on the surface plasmonic [98,99] and dye-quenching 
properties [100–102] of graphene to design a diverse range of highly-sensitive, very specific, extremely 
fast and low-noise biosensors for proteins and DNAs. The mechanisms involved include fluorescent 
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resonance energy transfer (FRET) [103–107], surface plasmon resonance (SPR) [108–111], surface 
enhanced Raman scattering (SERS) [93,112,113], and several other protocols.  
By exploiting the photoluminescence of GO and quenching ability of gold nanoparticles (AuNPs) 
for organic fluorophores, a series of FRET-based biosensors of GO arrays were realized towards 
aptasensing [105] and immunosensing [106] of proteins, and for the detection of sequence-specific 
DNA hybridization [107,114]. Correspondingly, probe biomolecules including aptamers [105], 
antibodies [106], ssDNAs and molecular beacons (MBs) [115,116] have been utilized in these 
selective FRET assays of proteins and nucleic acids (e.g., DNA bases and sequences). Generally, the 
capture of a target biomolecule is verified by the fluorescence quenching of GO by FRET between the 
fluorescent (i.e., NP)-tagged target and GO sheets. In Figure 1c, a typical FRET assay is illustrated for 
DNA-CdTe quantum dot (QD) conjugates with graphene [89]. In the case of Liu et al. [107], probe 
DNAs linked to the surface of GO by carbodiimide chemistry were hybridized with AuNPs labeled 
with the complementary target DNA strands, which correspondingly led to a decrease in fluorescence 
emission intensity from the GO arrays. Based on a similar principle of FRET, Jung et al. [106] have 
fabricated an alternate biorecognition assay for immunosensing. This biosensor was realized through 
the synthesis of AuNP-antibody (Ab) conjugates (Ab-AuNP-DNA complexes) via ssDNA linkers.  
In particular, DNA linkers were utilized to provide a control of distance between Ab and AuNPs, such 
that AuNPs could quench the fluorescence while bound to the GO surface. The high affinity of amino 
functional groups of DNA nucleotides for AuNPs led to an enhancement in the quenching efficiency of 
GO. Consequently, target biomolecules on the GO surface were identified through a specific binding 
with Ab-dsDNA-AuNP complexes, which resulted in a reduction of fluorescence emission by the GO 
arrays. Furthermore, while fluorescent tags such as quantum dots [104,117] and NPs have been 
commonly employed in FRET-based assays, a novel protocol for sequence-specific DNA sensing was 
recently developed [103], which utilizes the fluorescence from aggregation-induced emission (AIE) 
molecules. In particular, 9,10-distyrylanthracene with two ammonium groups (DSAI) were used in  
a novel AIE probe, and the fluorescent aptasensor based on DSAI and GO was developed for selective 
and sensitive detection of targeted DNA and thrombin proteins. 
On the other hand, SPR biosensors utilize the propagation of surface plasmon polariton (SPP) 
waves to probe the interactions between biomolecules and the sensing surface. In particular, graphene 
has been employed as a functional coating to enhance the SPR signal and the immobilization of probe 
biomolecules. For instance, Wu et al. [111] have achieved a superior performance in biomolecular 
recognition for graphene-on-gold compared to gold-only platforms in SPR-based biosensors.  
As the graphene coating improves the propagation of surface plasmon polaritons, it consequently  
enhances the device sensitivity to changes in its refractive index. Additionally, the detection of  
biomolecules with carbon-based ring structures (e.g., ssDNA) was discovered to be well supported by  
graphene-on-Au SPR biosensors. This stems from an increased bioaffinity to the surface of graphene 
through π-stacking of sp2 orbitals, and consequently enhances the device sensitivity. On the detection 
of proteins, Zhang et al. [109,110] have established an SPR biosensor composed of GO decorated with 
gold nanostrucutre-antibody conjugates for a specific measurement of the antigen content. The large 
specific surface area and abundant oxygen-containing functional groups of GO had facilitated the 
immobilization of gold nanorod (AuNR)–antibody conjugates on its surface [110]. Meanwhile, AuNRs 
anchored to the GO surface function as SPR signal enhancers which greatly improved sensitivities in 
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the determination of transferrin, as evident by the limit of detection which was reported to be 32 times 
lower than that obtained with continuous Au films. Moreover, Wang et al. [108] have demonstrated  
a label-free and regenerative SPR biosensor for α-thrombin, composed of noncovalently adsorbed  
α-thombin-specific aptamers to the surface of reduced GO (RGO) coated Au films. The detection 
mechanism involves a detachment of α-thrombin-specific aptamers from the SPR biorecognition 
surface upon binding with α-thrombin, and leads to a noticeable change in the SPR resonant angle 
within a detection limit of 0.05 nM. 
Indeed, as the surface of graphene may be decorated with NPs to amplify the SPP waves, this 
facilitates its applicability to SERS-based substrates for single molecule detection [93,96,112,113,118]. 
For instance, Liu et al. [119] have designed an AgNP functionalized GO for an ultrasensitive detection 
of aromatic molecules with various charges including, positively charged crystal violet (CV), 
negatively charged amaranth, and neutral phosphorus triphenyl (PPh3). This may be adapted for the 
determination of charged molecules including proteins and DNAs (phosphate backbone). Furthermore, 
Lu et al. [113] have established a SERS substrate based on an RGO film decorated with silver (Ag) 
NPs for the sensing of aromatic molecules. In comparison with graphene-only substrates, this AgNP-RGO 
composite shows a superior sensitivity, and a detection limit in the order of nM. Moreover, this may be 
harnessed to monitor the levels of aromatic residues namely, Amyloid-related proteins and short 
peptide fragments, which precede the formation of Amyloid fibrils in AD. An analogous setup for 
DNAs was tailored by He et al. [93] (Figure 1d), in which a multiplexed and sequence-specific 
detection was achieved. In particular, this involved a SERS-active substrate based on AuNP-decorated 
CVD-growth graphene. Due to the combination of AuNPs and graphene, the Raman signals of dye 
were electrochemically enhanced [120,121] by this novel substrate. With the AuNPs, DNA capture 
probes were assembled on the surface of graphene films. Consequently, it was reported that two 
different DNA targets sharing a substrate could be simultaneously determined (down to 10 pM) with  
a single light source. 
2.3. Plasma-Processing: Graphene 
The importance of plasma-treatment in graphene-based biosensors is three-fold, namely, to assist 
fabrication, enhance sensitivities, and enable the tailoring of functionalities, via rapid, scalable, versatile, 
and contaminant-free procedures (Figure 2). For instance, the synthesis of graphene via (H2/CH4) 
plasma-enabled chemical vapor deposition (PECVD) on Cu [122] or atmospheric pressured (CH4/H2/Ar) 
PECVD on SiO2 [123,124] present an energy efficient, high-quality yield and low temperature  
(~600 °C) alternative to the conventional methods such as thermal CVD (900–1000 °C) [125], thermal 
decomposition of SiC wafer [126], mechanical exfoliation of bi/tri-layer graphene [127,128], thermal 
annealing [129–131], and chemical [129,132,133] and photocatalytic [134,135] reduction from 
graphene oxide. On the other hand, surface functional groups of nanostructures created in a plasma 
environment are dependent on the active species and the specific plasma conditions. For example, 
high-pressure (e.g., at atmospheric pressure) plasmas features an environment with low ion collision 
frequencies, hence reducing damages on nanostructures induced by the highly energetic ions. By 
avoiding complex vacuum technologies, these high-pressure plasmas are also suitable for direct in-line 
surface modifications. In contrast, low-pressure plasmas are advantageous in providing a high uniform 
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and deep treatment to the nanostructures, due to the uniform processing environment with less ion 
collisions under the high vacuum.  
Notably, the restoration of GO may be most efficiently achieved via plasma-treatment [123], as 
evidenced by the superior electrical conductivity of RGO and its structural characterization illustrated 
in Figure 2a–d. Flakes of GO (Figure 2a) were treated by H2 plasma (10 mins at 525 °C), for the 
production of highly uniform reduced graphene oxide (RGO) sheets (Figure 2b). Correspondingly, the 
Raman spectra in Figure 2c demonstrates the quality and impact of plasma-assisted reduction of GO 
(i.e., “as-made”) to RGO. The plasma-assisted restoration of GO results in a decrease in ID/IG  
(D/G peak intensity) ratio from 1.03 (“as-made”) to 0.53 after 10 min of plasma exposure. As ID/IG is 
proportional to the average size of the sp
2
 carbon domains, this decrease in ID/IG is attributed to the 




 carbons. In Figure 2d, the C1 XPS spectra of GO 
after 10 min of plasma treatment further highlights the superior quality of graphene obtained via 
plasma-assisted reduction. In particular, a dominant C-C peak corresponds to the removal of most 
oxygen functional groups. This will not only amplify the sensitivities in graphene-based biosensors, 
but also provides a non-toxic and scalable substitute to typical hazardous wet chemical methods, such 
as hydrazine or sodium borohydride treatments, which may introduce significant impurities and defects.  
Figure 2. Structures and morphologies of graphene oxide (GO) under plasma-assisted 
reduction and decoration with nanoparticles (NPs). Atomic force microscopy (AFM) 
characterization of (a) GO and (b) reduced graphene oxide (RGO) sheets after 10 min of 
H2 plasma treatment at 525 °C; (c) The Raman spectra showing the quality and impact of 
plasma-assisted reduction of GO (i.e., “as-made”) to RGO; (d) The C1 XPS spectra of GO 
after 10 min of plasma treatment. Reproduced from [123]; (e) Transmission electron 
microscopy (TEM) image of nitrogen-doped graphene. Inset shows the selected-area 
electron diffraction (SAED). Reproduced from [136]; (f) High-resolution TEM image of 
GO nanosheets uniformly decorated with palladium (Pd)-NPs via a low temperature 
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Moreover, plasma-treatment of graphene promotes the tailoring of functionalities for the realization 
of specific biorecognition domains. In particular, the controlled doping and oxidation of graphene 
outlines the two essential plasma-specific activations. Firstly, N2 plasma may be utilized to simultaneously 
dope and reduce GO to a high quality [136] (Figure 2e). Indeed, the doping of graphene enables the 
attachment of amino functional groups which facilitate the immobilisation of analyte-specific 
bioreceptors (e.g., antibodies, antigens, or ssDNAs) to enable specificity in biosensing. Moreover,  
as the photoluminescence of graphene may be enhanced upon oxidation with O2 plasma, this presents 
an opportunity to fabricate highly-sensitive and selective platforms for FRET-based protein recognition 
by a faster, cheaper, and health-benign alternative of plasma-activation. This is important because 
chemically toxic treatments involving concentrated acids may induce significant substrate defects or 
unwanted impurities. Lastly, the plasma treatment may be utilized to produce GO-NP composites with 
a good dispersion of NPs (Figure 2f) [137,138]. 
3. Carbon Nanotubes 
Carbon nanotubes (CNTs) are hollow graphitic nanomaterials comprised of cylindrical sp
2
-hybridized 
carbon atoms. CNTs exist in two principle forms, single-walled (i.e., SWCNT) and multi-walled  
(i.e., MWCNT). The former is characterised by a one-dimensional tubular graphene sheet (1–2 nm 
diameter) [139–141], and the latter as concentric, closed graphite tubules, of diameter 2–50 nm with  
sub-nanometer (~0.35 nm) interlayer spacing [142–144]. CNTs have many properties that are desired 
for biosensors, such as semiconducting characteristics, excellent electrical conductivity, high aspect ratio, 
mechanical integrity, and chemical stability. Consequently, CNTs have been integrated into numerous 
electrical (Section 3.1) and optical (Section 3.2) platforms, for the determination of biological 
complexes including, but not limited to, nucleic acids and protein biomarkers. In addition, due to the 
unique morphology of CNTs, three variants in biorecognition substrates, namely, single CNT 
platforms, randomly distributed CNT arrays, and vertically aligned CNT forests, have been realized. 
3.1. CNT-Based Electrical Biosensors 
The ability of CNTs to promote charge transfer has been a crucial aspect to its multiple successes  
in implementations towards electrical biosensors. CNT-based substrates with FET characteristics have 
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offer a highly-sensitive, label-free, and real-time detection. Typically, target analytes are detected by 
measuring a change in electrical conductivity across the CNT-FET channel caused by their binding 
with bioreceptors immobilized on the CNT surface. In FETs with horizontally aligned arrays of CNTs 
(Figure 3a), the detection of long or large biological complexes (e.g., DNAs, proteins) is challenged  
by a significant Debye screening beyond the CNT double layer. The strategies to overcome this 
problem have involved the use of small (few nm) receptors including, aptamers [151,158–160] and 
antibody-binding fragments [157,161], functionalized via NPs or chemical linkers with space-modifiers, 
on the walls of CNTs [153]. Yet another approach recently proposed by Oh et al. [145], involved  
the integration of CNTs to metal-semiconductor FETs (MESFETs). In particular, Oh et al. have designed 
a CNT-MESFET for a label-free, rapid, and highly sensitive (1 pg/mL) determination of Aβ in the 
human serum. A gold top gate was deposited on the middle of the CNT channel, where probe 
antibodies (protein A) were immobilized its surface. Subsequently, E. coli outer membranes were 
introduced to inhibit the non-specific binding of Aβ. The achieved 1 pg/mL detection limit not only 
presents a superior sensitivity to ELISAs for plasma Aβ, but also falls within the physiological range 
of Aβ in human serum. 
Figure 3. Carbon nanotubes (CNT)-based biosensors including FETs, vertically aligned 
CNT arrays for SERS, CNTs for Raman tags, and fluorometric CNT arrays. (a) Schematic 
of an electrolyte-gated CNT-FET, in which CNT walls were noncovalently functionalized 
with porphyrin-based glycoconjugates. Reproduced from [162]; (b) Outline of the 
vertically aligned CNTs functionalization with AuNDs with an atmospheric pressured plasma 
jet (APPJ). Reproduced from [163]; (c) Multi-color SWCNT Raman labels for multiplexed 





C (green) SWCNT Raman tags. Reproduced from [164]; (e) A SWCNT/chitosan 
suspension was spotted on glass and functionalized with Ni-NTA to bind His-tag-
containing capture proteins; (f) Illustration of the fluorescence change (ΔI/I0) following the 
immobilization of capture proteins and its subsequent binding with the analyte proteins on 
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Figure 3. Cont. 
 
3.2. CNT-Based Optical Biosensors 
The electronic and structural properties of SWCNTs have been essential towards its successful 
integration in optical biosensors. In particular, the (i) excellent Raman scattering cross-section of 
SWCNTs, and (ii) its ability to enhance Raman signals near optical transition [166], in conjunction 
with (iii) its near-infrared (NIR) band-gap fluorescence (i.e., semiconducting SWCNTs) [167], have 
been exploited in the design of highly-sensitive and selective optical assays for protein biomarkers and 
DNA sequences. On one hand, this includes SERS-active [163,168–170] label-free platforms, and on 
the other, fluorometric assays [164,165,171,172] and CNT Raman labels [164] in multiplexed 
biorecognition assays. Notably, Yick et al. [163] have demonstrated a hybrid three-dimensional (3D) 
nanostructure of vertically aligned carbon nanotubes (VACNTs) for an effective microscopic  
area-selective sensing platform based on SERS (Figure 3b). An atmospheric-pressure microplasma jet 
(APPJ) was utilized to produce 3D microfluidic channels on the dense arrays of multi-walled VACNTs. 
Correspondingly, these plasma-treated (hydrophilic) channels were chemically functionalized with Au 
nanodots, through their ability to confine the Au nanodot aqueous solution. Moreover, these NDs may 
be adapted to function as preferential sites for the subsequent attachment and sensing of biomolecules 
(e.g., antibodies, antigens, DNAs, etc.) onto these hybrid structures limited to the plasma-modified 
VACNTs. Chen et al. [164] have realized a novel multiplexed protein detection array, in which 
macromolecular SWCNTs were functionalized as multicolor Raman labels. In particular, Raman 
detection benefits from the sharp scattering peaks of SWCNTs with minimal background interference, 
and thus provides a high signal-to-noise ratio for ultra-sensitive detection. In combination with  
SERS-active substrates, the strong Raman intensity of SWCNT tags enabled protein detection sensitivity 
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proteinase 3, a biomarker for the autoimmune Wegener’s granulomatosis disease. Various antibodies 




C SWCNT isotopes (Figure 3c,d), and a multiplexed two-color SWCNT 
Raman-based protein assay was established. In addition, Ahn et al. [165] have harnessed the 
fluorescence of SWCNTs to pioneer the first chemical approach for a selective and label-free 
microarray for single protein recognition (Figure 3e,f). In particular, hexahistidine-tagged capture 
proteins directly expressed by cell-free synthesis on a SWCNT/chitosan microarray were bound to a 
Ni
2+
 chelated by Nα,Nα-bis(carboxymethyl)-L-lysine grafted to chitosan surrounding the SWCNT. 
The Ni
2+
 functioned as a proximity quencher with the Ni
2+
/SWCNT distance altered upon docking of 
the analyte proteins. This ability to discern single protein binding events decreased the detection limit 
from 100 nM, for the ensemble average, to 10 pM for an observation time of 600 s. More importantly, 
the versatility of cell-free synthesis to functionalize a nanosensor may be easily extended to include 
AD or PD biomarkers as capture proteins.  
3.3. Plasma-Processing: CNTs 
Plasma-processing of CNTs provides a practical and efficient tool for the independent control of surface 
temperature and surface passivation towards a deterministic control over nucleation, self-organisation 
and functionalization of the arrays of surface-supported CNTs [173,174]. Indeed, plasma-enabled CNT 
fabrication features remarkably lower temperatures (450 °C) [175–177], faster growth rates [178,179], 
denser growth patterns [180], and excellent morphological and structural features including superior 
defect-free SWCNTs, and a uniform distribution of CNT lengths and thickness across large patterns 
and arrays [180,181], as opposed to the conventional methods based on thermal CVD. The structures, 
morphologies, and the corresponding plasma-enabled growth mechanism for CNTs [180,182] are 
outlined in Figure 4. Figure 4a exemplifies a highly uniform and dense array of MWCNTs, grown by 
PECVD on nickel-coated glass. Acetylene gas was used as the carbon source, with ammonia gas for 
catalysis and dilution. Correspondingly, nanotubes with controllable diameters from 20 to 400 nanometers 




. In addition, 
these unique plasma-based treatments may be tailored to control the morphology of SWCNTs. In 
particular, Figure 4b illustrates a TEM of SWCNTs deposited on SiO2 wafer/ Si substrate via PECVD 
(<750 °C) with fast heating, for the pyrolysis of pure C2H2 carbon source at low pressure (30 mTorr), 
in order to obtain a high yield of semiconducting SWCNTs. 
Moreover, the incorporation of metal catalyst nanoparticles (CNPs), while essential for nucleation 
in the conventional thermal CVD synthesis of CNTs, remains detrimental for two primary reasons. 
Firstly, they impede direct integration into Si-dominated nanodevice platforms; and secondly, they 
contribute towards Ohmic losses in charge carrier transport along CNTs. Indeed, plasma processing in 
CNT growth addresses this concern at two fronts. Firstly, the direct integration of CNTs onto a Si 
nanodevice was enabled by high-density plasma treatment (CH4/N2 PECVD at 800 °C, high-vacuum 
10
−4
 Pa) [183]. Secondly, plasma-enabled CNT growth demonstrates a catalyst-free synthesis of linear 
arrays of vertically aligned CNTs (VACNTs), with variable and graded morphologies and structures 
tailored by the plasma density [183,184].  
Lastly, Figure 4d,e outline the growth of CNTs from CNP nucleation to termination, and the 
balance of carbon fluxes on surface-bound catalyst NPs/carbon nanostructures. In Figure 4e, the seven 
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main stages of the formation of the carbon nanostructure patterns on the surface are highlighted. 
Sequentially, this involves the (1) nucleation of metal CNPs on the surface; (2) growth of metal CNPs 
on the substrate surface; (3) carbon supply to the surface, formation of carbon fluxes on the substrate 
surface between the CNPs, initial saturation of metal CNPs with carbon; (4) formation of  
carbon-saturated metal NPs; (5) nucleation of carbon nanostructures on the carbon saturated metal 
catalyst particles; (6) growth of nanostructures on the carbon-saturated metal CNPs due to carbon 
influx through Ni; and (7) vertical growth due to carbon influx through Ni and carbon removal  
due to sputtering. 
Figure 4. Plasma-enabled growth of vertically aligned carbon nanotubes (CNTs), including 
CNT structures, morphologies, AuNP modification and growth mechanism. (a) MWCNTs 
fabricated on nickel-coated glass by PECVD. Reproduced from [185]; (b) TEM of 
SWCNTs deposited on SiO2 wafer/Si substrate via PECVD (<750 °C) with fast heating. 
Reproduced from [186]; (c) Vertically aligned CNTs treated by cold atmospheric-pressure 
micro-plasma jet (APMPJ) for the decoration of AuNDs. Reproduced from [163];  
(d) Overview of CNT growth from CNP nucleation to termination; (e) The seven main 




In general, plasmas can modify different nanostructures in a relatively homogeneous way and  
the stability of modified nanostructures can fulfill the real applications, provided that suitable plasma 
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conditions are implemented. For example, the fabrication of an SERS-based protein sensing platform, 
namely, a dense structure of vertically aligned CNTs and 4-ATP functionalised AuNDs, was enabled 
by a rapid (10–30 s) cold atmospheric-pressure micro-plasma jet (APMPJ) treatment [163]. In contrast 
to the conventional low-pressure plasma systems, APMPJ operates at low (mW-W) power, room 
temperature and atmospheric pressure. Moreover, plasma-assisted CNT synthesis enables a narrower 
chirality distribution of SWCNTs, and a pronounced vertical alignment to the substrate. The former 
features a production of semiconducting SWCNTs in large fractions (96%) [186], as opposed to  
the conventional thermal CVD [187]. Furthermore, a controlled transition of SWCNTs from metallic 
to semiconducting via H2 plasma treatment [188] facilitates the operation of FET-based CNT protein 
biosensors. Additionally, the surface of CNTs may be activated with amino and carboxyl functional 
groups, to enable the immobilisation of probe biomolecules including, but not limited to, antibodies, 
antigens, and aptamers [160,189]. Notably, a low temperature (NH3 [190] or CF4 [191]) plasma-assisted 
activation of CNT surface demonstrates a superior and controlled functionalization, via an energy efficient, 
inexpensive, and significantly less destructive procedure as opposed to the hazardous chemical doping.  
4. Carbon Nanowalls 
Carbon nanowalls (CNWs), also known as vertically-oriented graphenes (VGs), are self-organised 
and open 3D inter-networked arrays of graphene nanosheets, with individual nanosheets composed of 
few-layered graphenes, of subnanometer interlayer spacings (0.34–0.37 nm) spanning several 
micrometers in lateral dimensions [192–195]. The unique morphology of CNWs presents a high 
density of (open) active graphitic edges and free active basal planes standing on a substrate. This is 
complemented by their exceptional tensile strength, high electrical conductivity, semiconducting 
nature, chemical stability, and ease of functionality [196]. 
4.1. CNW-Based Biosensors 
The aforementioned unique features of CNWs have been harnessed in the design of FET  
devices [197] for immunosensing [198], electrochemical platforms for sequence-specific DNA 
detection [199,200], and novel absorbance [201] and plasmonic/SERS-active substrates [202,203] 
which may be tailored for the sensing of AD or PD biomarkers. For instance, Mao et al. [198] have 
developed a sensitive and selective FET biosensor with CNWs labeled with AuNP-antibody 
conjugates (Figure 5a). CNWs were directly grown on the sensor electrode via a single-step PECVD 
and functioned as a sensing channel. Subsequently, the protein detection was accomplished through the 
measurement of changes in the FET channel resistivity upon the antibody-antigen binding. Selectivity 
against immunoglobulin G (IgG), immunoglobulin M (IgM) and horse radish peroxide (HRP) was 
demonstrated at the ~2 ng/mL level. Moreover, this presents a single-step and reliable approach which 
may be adapted to prepare a label-free and real-time biosensing platform for AD or PD protein 
biomarkers. Arkhavan et al. [199] have fabricated a graphene oxide nanowall (GONW) electrode for a 
label-free and highly-sensitive (0.1 fM resolution) electrochemical detection towards the four bases of 
dsDNA and the SNPs of oligonucleotides. In particular, GONWs were electrophoretically deposited on 
a graphite electrode, and the oxidation signals of individual nucleotide bases were monitored by differential 
pulse voltammetry (DPV). Recently, Seo et al. [201] have pioneered (Ar/H2) plasma-grown VGs by 
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reforming natural honey precursors, which were subsequently decorated with AuNPs for Au-antibody 
sensing, whereby a SERS/SPR sensing platform may be facilitated by AuNPs (signal amplification) 
and shift in UV-Vis diffuse reflectance spectra. In particular, the N2 plasma treatment of the VGs 
enabled the tuning of UV-Vis transmission in VGs for protein sensing (e.g., BSA immobilised on 
VGs) via Raman spectroscopy and UV-Vis spectrophotometry [202]. Lastly, Rider et al. [202] have 
established a 3D SERS/plasmonic sensing platform based on a plasma-enabled and catalyst-free 
synthesis of CNWs decorated with self-organized AuNPs (Figure 5b). The controllable high 
“bookshelf-like” surface coverage of the CNW basal plane by self-organized AuNP arrays was 
achieved through the use of weakly ionized plasma-based processes. Consequently, the Raman 
fingerprints corresponding to the radial breathing-modes of CNWs were significantly amplified due to 
the presence of Au NPs.  
Figure 5. Carbon nanowalls (CNW)-based FET and plasmonic/SERS-active biosensing 
platforms. (a) A CNW substrate was decorated with AuNP-anti-IgG conjugates by 
electrodeposition, for the sensing of complementary IgGs. Reproduced from [198];  
(b) CNWs synthesized on Si(100) substrate via a catalyst-free N2 PECVD. The thermally 
evaporated AuNPs were self-assembled onto the CNWs as a SERS platform. Reproduced 
from [202].  
(a)  
(b)  
4.2. Plasma-Processing: CNWs 
First and foremost, plasma processing of CNWs provides a fast, single-step, energy-efficient and 
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functionalizing CNWs through plasma-activation presents an eco-friendly and inexpensive procedure 
as opposed to hazardous wet-chemical methods which may introduce significant defects and impurities. 
Figure 6 illustrates the structures, morphologies and plasma-enabled growth mechanism of CNWs.  
In particular, CNW fabrication by PECVD via MW (CH4/H2), RF (CH4/Ar), electron beam excited 
(CH4/H2), helicon wave-excited (CH4), and DC (CH4/H2/Ar) plasmas [204–208], have demonstrated a 
catalyst-free, energy-efficient, and low-temperature (400–800 °C) alternative to non plasma-assisted 
methods including, sputtering (glassy carbon target) in CH4/Ar gas [209] and hot filament CVD in a 
CH4/H2 or CH4/He background gas [210–212], which primarily utilize expensive purified hydrocarbon 
gases in high-temperature environments (700–1000 °C) while involving long fabrication times  
(20–45 min). Furthermore, recent advances in CNW synthesis has established a single-step, fast, 
scalable and environmentally-benign (Ar/H2 RF) plasma-enabled CNW growth from natural precursors, 
demonstrating good VG-substrate adhesion and controllability over the degree of graphitization and 
density of VG edge planes [213,214].  
Figure 6. Structures, morphologies, and growth mechanism for plasma-enabled  
catalyst-free growth of few-layer CNWs. (a) High-resolution SEM of ultra-thin CNWs 
produced from natural honey; (b) high-resolution TEM image of the graphitic edges of 
CNWs. Reproduced from [201]; (c) CNWs with self-organised AuNP arrays;  
(d) high-resolution TEM image of 4-layer VGs. Reproduced from [202]; (e) AuNPs 
introduced into CNWs by electrodeposition. Reproduced from [198]; (f) growth model for 
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5. Conclusions and Outlook 
The excellent inherent electrical, optical, and structural properties of CNs render them essential for 
implementation in biosensors and bioassays. In addition, the sensing of biomarkers indicative of 
presymptomatic NDs (e.g., AD or PD) requires a biorecognition platform with unprecedented 
specificity and sensitivity in complex biological fluids such as blood and CSF directly. Moreover,  
a reproducible, inexpensive and resource-efficient device fabrication is necessary in order to develop  
a practical biosensor. To this end, we suggest an electrochemical CNW-based substrate to be the most 
viable platform for the detection of AD or PD biomarkers. CNWs can be directly grown on various 
conductive substrates so as to reduce the fabrication steps and cost associated with the production of 
the sensing systems. At present, while only a handful of CNWs-based biosensors for metabolites, 
proteins and DNAs have been developed, they have consistently demonstrated comparable or improved 
sensitivities, selectivities, dynamical ranges, and fabrication costs, as compared to biosensors made of 
CNTs and graphene (see Table 1). In particular, the ease of electrode fabrication, coupled with the 
inherent properties of graphene, reactive open edges and high NP loading capacity of CNWs, may 
facilitate a highly sensitive, selective and rapid biosensing device. Consequently, an electrochemical 
sensor based on CNWs decorated with probe-functionalized (e.g., complementary antibody, fragments, 
or ssDNA) NPs may provide the most effective approach for a selective determination of CSF protein 
biomarkers, and a sequence-specific detection of DNA biomarkers. In addition, probe biomolecules 
may be customized to capture the neurotoxic Aβ42 oligomeric species while in human CSF [216], target 
specific regions of Aβ for the differentiation between various oligomers [29] and conformers [217,218], 
or be replaced with phospholipid-specific biomolecules [219], for the detection of blood-based 
phospholipid biomarkers. Alternatively, Aβ-specific ligands may be employed as bioreceptors ([220] 
and references therein) to reduce the fabrication costs associated with antibody or antigen probes.  
Moreover, plasma-based techniques for fabrication and surface treatment may be implemented to 
most effectively enable, enhance, and tailor the device performance and optimize the fabrication 
processes of CNs towards the construction of biosensing devices with superior properties, via a plethora 
of energy-efficient, environmentally-benign, and inexpensive approaches, for future healthcare 
applications. In particular, by harnessing these unique and beneficial plasma-based techniques for  
the surface modification of CNWs, this highlights a great promise towards the fabrication of  
an ultrasensitive, ultraselective, and cost-efficient biosensor, for an early diagnosis of NDs. More 
specifically, these plasma-based approaches offer a highly effective and efficient functionalization of 
CNs. Consequently, this promotes a facile immobilization of highly specific probe biomolecules  
(e.g., antibodies, antigens, aptamers, and other selective receptors), and hence, may enable a highly 
versatile and selective biorecognition device capable of detecting ND biomarkers in complex 
biological fluids such as blood and CSF. Furthermore, these sensing strategies may be tailored to 
facilitate a range of highly promising therapeutics for the prevention and treatment of NDs. For 
example, this may involve the inhibition of biomolecules such as mRNA [221], β secretase [222], and 
interleukin-12/23 [223], whose expressions are crucial in the early stages of ND pathogenesis. 
However, further research in the biocompatibility of CNs remains highly warranted [224]. Notably, the 
integration of plasma-enabled CNs in the next-generation of biosensors presents a promising solution 
for the realization of devices, which may be tailored for the early diagnosis of a diverse spectrum of 
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life-threatening diseases (e.g., diabetes, cancer, and cardiovascular diseases) in addition to the 
neurodegenerative diseases. 
Table 1. A survey of CN-based biosensors that have been realized for the detection  
of metabolism-related biomolecules, DNAs and proteins. These biosensors have been 
selected to illustrate the varying specificity, sensitivity and fabrication approaches for 
various CN substrates (i.e., CNWs, CNTs or graphene), biomolecules of interest, and 
transduction mechanisms. 
Sensors Target analyte Detection limit Detection range Reference 
CNWs on graphite electrode DNAs 9.4 zM  0.1 fM–10 mM [199] 
GO with sulfonated polyalinine DNAs 5.2 fM 0.1 µM–10 fM [225] 
CNWs on Si Metabolites  0.17 µM 1–100 µM [226] 
CNWs on Ti-coated Si Metabolites 0.3 µM 0.01–50 mM [227] 
CNWs on Au Immunoglobulins 2 ng/mL 2–20 ng/mL [198] 
CNTs DNAs 100 aM 100 aM–1 pM [228] 
CNT-based FETs DNAs 0.1 mg/mL – [229] 
Nitrogen-doped MWCNTs Glucose 10 µM 0.02–1.02 mM [230] 
MWCNTs with GOx and Au NPs Glucose 20 µM 0.05–22 mM [231] 
SWCNTs on SiO2 Immunoglobulins 1 pg/mL 100 fg/mL–1000 pg/mL [157] 
SWCNTs on SiO2 Immunoglobulins 1 pg/mL 1–1000 pg/mL [145] 
Functionalized SWCNTS Immunoglobulins 1 fM 100 pM–1 fM [164] 
Graphene DNAs 0.12 pM 1 pM–0.1 µM [232] 
Graphene on SiO2 DNAs 10 pM 10 pM–100 nM [93] 
N-doped graphene oxide Immunoglobulins 0.012 U/mL 0.1–20 U/mL [75] 
Graphene oxide with Au NPs Immunoglobulins 1 pM 1 pM–1 µM [70] 
Graphene oxide with Au NPs Immunoglobulins 0.0375 µg/mL 0.0375–40 µg/mL [110] 
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